PARIS (Reuters) – U.S. company Regeneron Pharmaceuticals said it had agreed to repurchase approximately $5 billion of its shares directly from French drugmaker Sanofi.
Sanofi, which holds about 23.2 million Regeneron shares, said separately it intended to sell its equity investment, and that the move would not change ongoing collaboration between the two groups.
(Writing by Matthieu Protard; editing by John Stonestreet)
Eagles lose to Commanders, 36-33, as Hurts exit looms large
Flyers mount comeback win over Blue Jackets
An imperfect ten: Giants skid hits double-digits in blowout loss to Falcons
Aaron Rodgers’ fumble, bad fourth-down gambles lead Jets to another second-half collapse, loss to Rams
‘A Philly Special Christmas’ raises over $3 million for local children
NYC Christmas trees return to the Earth during Mulchfest 2025
City Council approves prison oversight legislation, ballot questionAaron Rodgers’ fumble, bad fourth-down gambles lead Jets to another second-half collapse, loss to Rams
Woman burned alive while sleeping on Brooklyn F train; person of interest in custody‘A Philly Special Christmas’ raises over $3 million for local children
